英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Valproic Acid Related Compound A |
丙戊酸相關(guān)物質(zhì)A |
99-67-2 |
詳細(xì)
|
Tacrolimus 8-Epimer/8-epi Tacrolimus |
他克莫司雜質(zhì) |
129212-35-7 |
詳細(xì)
|
4-bromo-1-tert-butyl-1H-pyrazole |
4-溴-1-叔丁基吡唑 |
70951-85-8 |
詳細(xì)
|
IsoCyclosporinH |
異構(gòu)環(huán)孢菌素h |
83602-43-1 |
詳細(xì)
|
1-tert-Butyl-1H-pyrazole |
1 -叔丁基吡唑 |
15754-60-6 |
詳細(xì)
|
Citalopram impurity 8/Citalopram N-Oxide HCl/Escitalopram EP Impurity H HCl/Citalopram Related Compound E HCl/1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-N-oxide hydrochloride |
鹽酸艾司西酞普蘭EP雜質(zhì)H (西酞普蘭N氧化物HCL) |
62498-71-9 |
詳細(xì)
|
1-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
1-(叔丁基)-4-(4,4,5,5-四甲基-1,3,2-二氧硼雜環(huán)戊烷-2-基)吡唑 |
1256359-15-5 |
詳細(xì)
|
Mirtazapine EP Impurity C/Mirtazapine Lactam/2-Methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one |
米氮平雜質(zhì) |
191546-96-0 |
詳細(xì)
|
Mirtazapine Carboxylic Acid/1-(3-Carboxy-2-pyridyl)-4-methyl-2-phenylpiperazine |
米氮平雜質(zhì) |
61338-13-4 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity B/1-(2-Morpholinoethoxy) Mycophenolate Mofetil/2-Morpholinoethyl (E)-6-[1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-1-(2-morpholinoethyl)-3-oxo-5-isobenzofuranyl]-4-methyl-4-hexenoate |
霉酚酸嗎啉乙酯雜質(zhì) |
1094322-91-4 |
詳細(xì)
|
Abiraterone Acetate 5,6-Dihydro Impurity/17-(3-Pyridinyl)-(3β,5α)-Androst-16-en-3-ol acetate |
(3S,5S,8R,9S,10S,13S,14S)-10,13-二甲基-17-(吡啶-3-基)-2 |
219843-76-2 |
詳細(xì)
|
MirtazapineCyanoImpurity |
米氮平雜質(zhì) |
61337-88-0 |
詳細(xì)
|
Abiraterone Acetate 5,6-Epoxide/(3β,5α,6α)-5,6-epoxy-17-(3-pyridinyl)-3-androst-16-en-3-ol-3-acetate |
Abiraterone Acetate 5,6-Epoxide/(3β,5α,6α)-5,6-epoxy-17-(3-pyridinyl)-3-androst-16-en-3-ol-3-acetate |
1868064-50-9 |
詳細(xì)
|
BrompheniramineN-Oxide |
BROMPHENIRAMINE N-OXIDE |
18453-29-7 |
詳細(xì)
|
Abiraterone 3-Oxo 4,5-Dihydro Impurity/(8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-1,7,8,9,10,11,12,13,14,15-decahydro-2H-cyclopenta[a]phenanthren-3(6H)-one |
阿比特龍代謝物 |
154229-21-7 |
詳細(xì)
|
N-DespropylPropafenoneHCl |
鹽酸普羅帕酮 |
1188263-52-6 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity G/Mycophenolate Mofetil N-Oxide/2-(Morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate N-oxide |
霉酚酸嗎啉乙酯雜質(zhì) |
224052-51-1 |
詳細(xì)
|
Mirtazapine EP Impurity F/Mirtazapine 10-Keto Impurity/2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one |
米氮平雜質(zhì) |
191546-97-1 |
詳細(xì)
|
Mirtazapine EP Impurity B/[2-[(2RS)-4-Methyl-2-phenylpiperazin-1-yl]pyridin-3-yl]methanol |
米氮平雜質(zhì) |
61337-89-1 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity A/O-Desmethyl Mycophenolate Mofetil/2-Morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate |
霉酚酸嗎啉乙酯雜質(zhì) |
1322681-36-6 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity D/O-Methyl Mycophenolate Mofetil/2-(Morpholin-4-yl)ethyl (4E)-6-(4,6-dimethoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate |
霉酚酸嗎啉乙酯雜質(zhì) |
1322681-37-7 |
詳細(xì)
|
Ethyl Mycophenolate/(E)-Ethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate |
霉酚酸嗎啉乙酯雜質(zhì) |
32483-51-5 |
詳細(xì)
|
MirtazapineEPImpurityE |
米氮平EP雜質(zhì)E |
191546-94-8 |
詳細(xì)
|
MirtazapineEPImpurityA |
米氮平雜質(zhì) |
155172-12-6 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity E/Mycophenolic Acid Methyl Ester/(4E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid Methyl Ester |
霉酚酸嗎啉乙酯雜質(zhì) |
31858-66-9 |
詳細(xì)
|
Mycophenolate Mofetil EP Impurity H/Mycophenolic Lactone/Mycophenolate Sodium EP Impurity A/(RS)-7-Hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydro-furan-5-yl)-ethyl]-3H-isobenzofuranyl-1-one |
霉酚酸嗎啉乙酯雜質(zhì) |
26675-76-3 |
詳細(xì)
|
Mycophenolate Dimethylamide/(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-N,N,4-trimethylhex-4-enamide |
霉酚酸嗎啉乙酯雜質(zhì) |
59058-64-9 |
詳細(xì)
|
Formoterol EP Impurity D Fumarate/N-Methyl Formoterol Fumarate (2:1) (Mixture of Diastereomers)/N-[2-Hydroxy-5-[1-hydroxy-2-[methyl[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide Fumarate Salt (2:1) |
IECWPBVJPVCKJS-WLHGVMLRSA-N |
1795133-97-9 |
詳細(xì)
|
Trazodone BP Impurity H/1,3-Bis-[4-(3-chlorophenyl)piperazin-1-yl]propane |
曲唑酮雜質(zhì) |
6323-09-7 |
詳細(xì)
|
N-(2-Aminoethyl)-1-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)piperidine-3-carboxamide |
|
2220185-45-3 |
詳細(xì)
|
Chlorpheniramine |
2-(4-氯苯基)-4-(二甲氨基)-2-吡啶丙胺 |
132-22-9 |
詳細(xì)
|
Pitavastatin impurity 12//Pitavastatin Methyl Ester/(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid methyl ester |
匹伐他汀甲酯 |
849811-78-5 |
詳細(xì)
|
Itopride impurity 7/Itopride N-4-Hydroxybenzyl/N-(4-Hydroxybenzyl)-3,4-dimethoxybenzamide |
N-(4-羥基芐基)-3,4-二甲氧基苯甲酰胺 |
943518-63-6 |
詳細(xì)
|
Itopride impurity 9/Itopride N-4-Methoxybenzyl/N-(4-Methoxybenzyl)-3,4-dimethoxybenzamide |
Itopride Impurity B |
331239-23-7 |
詳細(xì)
|
Citalopram EP Impurity B Oxalate(3-Hydroxy Citalopram Oxalate) |
西酞普蘭雜質(zhì)B |
1332724-03-4 |
詳細(xì)
|
Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
1440961-11-4 |
詳細(xì)
|
Pitavastatin Lactone/Itavastatin Lactone/(4R,6S,E)-6-[2-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl] vinyl] tetrahydro-4-hydroxypyran-2-one |
匹伐他汀內(nèi)酯 |
141750-63-2 |
詳細(xì)
|
Itopride impurity 8/4-(2-(dimethylamino)ethoxy)benzaldehyde oxime |
苯甲醛, 4-[2-(二甲胺基)乙氧基]-, 肟 |
3421-72-5 |
詳細(xì)
|
4-Fluoro-1-naphthaldehyde |
4-氟-1-萘甲醛 |
172033-73-7 |
詳細(xì)
|
3-Thiophenecarboxylic acid, 2-bromo-4-(trifluoromethyl)-, methyl ester Methyl 2-bromo-4-(trifluoromethyl)thiophene-3-carboxylate |
2-溴-4-(三氟甲基)噻吩-3-羧酸甲酯 |
1853236-69-7 |
詳細(xì)
|
6-Bromopyridine-2-carboxylic acid amide |
6-溴吡啶甲酰胺 |
25194-52-9 |
詳細(xì)
|
Propane-1-sulphonamide |
丙基磺酰胺 |
24243-71-8 |
詳細(xì)
|
2,3-Dihydro-1H-indene-1-carbonitrile |
2,3-二氫-1H-茚-1-甲腈 |
26452-97-1 |
詳細(xì)
|
3-Chromanecarboxylic acid |
苯并二氫吡喃-3-甲酸甲酯 |
115822-57-6 |
詳細(xì)
|
Valaciclovir EP Impurity C/Valaciclovir USP RC C |
伐昔洛韋EP雜質(zhì)C |
1346747-65-6 |
詳細(xì)
|
2-Propanamine, 1,3-bis(2-propen-1-yloxy)-2-[(2-propen-1-yloxy)methyl]- |
|
401894-90-4 |
詳細(xì)
|
KB-R7943 |
KB-R7943 甲磺酰酸鹽 |
182004-65-5 |
詳細(xì)
|
FesoterodineDiolRacemate |
苯甲醇, 3-[3-[雙(1-甲基乙基)氨基]-1-苯基丙基]-4-羥基- |
200801-70-3 |
詳細(xì)
|
NaproxenEPImpurityC(5-BromoNaproxen) |
萘普生雜質(zhì) |
84236-26-0 |
詳細(xì)
|
SulfamethoxazoleRelatedCompoundF |
SulfaMethoxazole Related CoMpound F |
17103-52-5 |
詳細(xì)
|
Bromobetamethasone21-Acetate |
6α-Bromobetamethasone 21-Acetate |
52618-94-7 |
詳細(xì)
|
Bupropion Related Compound C |
安非他酮雜質(zhì)C |
152943-33-4 |
詳細(xì)
|
Bosentan USP RC C |
波生坦USP相關(guān)物質(zhì)C |
1097263-60-9 |
詳細(xì)
|
Epiprednisolone Disodium Phosphate |
|
|
詳細(xì)
|
Valsartan Related Compound E |
纈沙坦甲酯 |
137863-17-3 |
詳細(xì)
|
DiphenhydramineEPImpurityA |
2-(DIPHENYLMETHOXY)-N-METHYLETHYLAMINE |
17471-10-2 |
詳細(xì)
|
TVB-3664 |
TVB-3664 |
2097262-58-1 |
詳細(xì)
|
Hydroxychloroquine EP Impurity D/Desethyl Chloroquine |
羥基氯喹EP雜質(zhì)D-d5二鹽酸 |
1476-52-4 |
詳細(xì)
|
Nifedipine EP Impurity A/Dehydro Nifedipine |
4 - (2硝基苯基)-2,6 -二甲基吡啶-3,5二羧酸二甲酯 |
67035-22-7 |
詳細(xì)
|
Diazepam EP Impurity B |
2-(N-甲基氯乙酰氨)-5-氯二苯甲酮 |
6021-21-2 |
詳細(xì)
|
AcemetacinEPImpurityF/CarboxymethylAcemetacin/[[[[[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl]oxy]acetyl]oxy]acetic acid |
阿西美辛EP雜質(zhì)F |
76812-49-2 |
詳細(xì)
|
Acemetacin EP Impurity D/6-t-Butyl Acemetacin/[[[1-(4-Chlorobenzoyl)-6-(1,1-dimethylethyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl]oxy]acetic acid |
阿西美辛EP雜質(zhì)D |
76812-64-1 |
詳細(xì)
|
PropafenoneEPImpurityB |
普羅帕酮雜質(zhì)B |
88308-22-9 |
詳細(xì)
|
Trazodone BP Impurity D HCl/Trazodone USP RC D HCl/Trazodone Bromo Analog HCl/3-Dechloro-3-bromo Trazodone Hydrochloride/2-[3-[4-(3-Bromophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride |
曲唑酮雜質(zhì) |
1263278-80-3 |
詳細(xì)
|
Acemetacin EP Impurity E/1,1-Dimethylethyl [[[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl]oxy]acetate |
阿西美辛EP雜質(zhì)E |
75302-98-6 |
詳細(xì)
|
PropofolEPImpurityB |
丙泊酚EP雜質(zhì)B |
74926-89-9 |
詳細(xì)
|
Trazodone EP Impurity I/1,4-Bis(3-chlorophenyl)-piperazine |
曲唑酮雜質(zhì) |
79975-63-6 |
詳細(xì)
|
Valecobulin hydrochloride |
1240321-53-2 |
1240321-53-2 |
詳細(xì)
|
PCO371 |
PCO371 |
1613373-33-3 |
詳細(xì)
|
LoratadineUSPRCI |
氯雷他定雜質(zhì)I |
133330-56-0 |
詳細(xì)
|
Pitavastatin impurity 14/Pitavastatin N-Oxide Sodium Salt/(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-1-oxido-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid sodium salt |
匹伐他汀雜質(zhì)18 |
2276678-27-2 |
詳細(xì)
|
Bupropion Related Compound B HCl salt |
安非他酮雜質(zhì)B |
1049718-43-5 |
詳細(xì)
|
Ranitidine EP Impurity B Fumarate/Ranitidine USP Related Compound A Fumarate/Ranitidine Aminoethyl Fumarate/2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethanamine Fumarate |
雷尼替丁雜質(zhì)A |
91224-69-0 |
詳細(xì)
|
Trimethoprim EP Impurity B/Trimethoprim USP RC B/(2,4-Diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone |
甲氧芐啶相關(guān)物質(zhì)B |
30806-86-1 |
詳細(xì)
|
Methionine EP Impurity D(racemic mixture)/(2S)-2-(2-acetamido-4-(methylthio)butanamido)-4-(methylthio)butanoic acid |
蛋氨酸EP雜質(zhì)D |
1879009-96-7 |
詳細(xì)
|
Levofloxacinimpurity18/N-EthylLevofloxacin/(3S)-10-(4-Ethyl-1-piperazinyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicAcid |
左氧氟沙星雜質(zhì)R |
106939-30-4 |
詳細(xì)
|
FlunarizineEPImpurityBDiHCl |
氟桂利嗪雜質(zhì)5 |
27064-96-6 |
詳細(xì)
|
HydroxychloroquineO-Acetate/2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol1-acetate |
羥氯喹雜質(zhì)7 |
47493-14-1 |
詳細(xì)
|
Chlorpromazine impurity 9/Chlorpromazine EP Impurity F HCl/3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine hydrochloride |
鹽酸氯丙嗪雜質(zhì)B |
72372-62-4 |
詳細(xì)
|
Nimesulide EP Impurity E |
N-(甲基磺?;?-N-(2-苯氧基苯基)甲烷磺酰胺 |
905858-63-1 |
詳細(xì)
|
Benzydamine N-Oxide |
benzydamine N-oxide |
36504-71-9 |
詳細(xì)
|
HydroxychloroquineEPImpurityC/DesethylHydroxychloroquine/Cletoquine/2-[[(4RS)-4-[(7-Chloroquinolin-4-yl)amino]pentyl]amino]ethan-1-ol |
克尼托喹 |
4298-15-1 |
詳細(xì)
|
AcetylMethionineSulfone(R/Smixture) |
|
169168-64-3 |
詳細(xì)
|
N-Desethyl N-Methyl rac-Rivastigmine |
酒石酸卡巴拉汀雜質(zhì)B |
25081-93-0 |
詳細(xì)
|
Bisoprolol Epoxide Impurity |
[[4-[[2-(1-甲基乙氧基)乙氧基]甲基]苯氧基]甲基]環(huán)氧乙烷 |
66722-57-4 |
詳細(xì)
|
Thiamine EP Impurity H |
[(4-氨基-2-甲基-5-嘧啶)甲基]二硫代氨基甲酸鹽(或酯) |
89285-03-0 |
詳細(xì)
|
Chlorambucil |
苯丁酸氮芥 |
305-03-3 |
詳細(xì)
|
Nimesulide EP Impurity F |
尼美舒利EP雜質(zhì)F |
51765-72-1 |
詳細(xì)
|
Losartan Carboxaldehyde |
氯沙坦甲醛 |
114798-36-6 |
詳細(xì)
|
2-[(3S)-3-[3-[(1E)-2-(7-Chloro-2-Quinolinyl)Ethenyl]Phenyl]-3-Hydroxypropyl]Benzoate |
[S-(E)]-2-[3-[3-[2-(7-氯-2-喹啉基)乙烯基]苯基]-3-羥基丙基]苯甲酸甲酯 |
181139-72-0 |
詳細(xì)
|
Topiramate N-Methyl Impurity/2,3:4,5-bis-O-(1-Methylethylidene)-β-D-fructopyranose 1-(N-methylsulfamate) |
托吡酯N-甲基雜質(zhì) |
97240-80-7 |
詳細(xì)
|
Dextromethorphan EP Impurity D |
右美沙芬EP雜質(zhì)D |
1453167-99-1 |
詳細(xì)
|
Mirtazapine EP Impurity D HCl/N-Desmethyl Mirtazapine HCl/1,2,3,4,10,14b-Hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine hydrochloride |
米氮平雜質(zhì) |
1188265-41-9 |
詳細(xì)
|
RivastigmineEPImpurityD |
卡巴拉汀雜質(zhì)異構(gòu)體對(duì)照品10 |
415973-05-6 |
詳細(xì)
|
Pramipexoleimpurity16/PramipexoleEPImpurityBDiHCl/N2-PropylPramipexoleDiHCl/(S)-2-Propylamino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazoledihydrochloride |
(S)-N2,N6-二丙基-4,5,6,7-四氫苯并[D]噻唑-2,6-二胺 |
1802051-36-0 |
詳細(xì)
|
Promethazine Sulfoxide |
異丙嗪亞砜 |
7640-51-9 |
詳細(xì)
|
Cyclobenzaprine N-Oxide |
環(huán)苯扎林N-氧化物 |
6682-26-4 |
詳細(xì)
|
Fluvastatin N-Ethyl Impurity Sodium Salt |
氟伐他汀雜質(zhì) |
93936-64-2 |
詳細(xì)
|
Metamizole Impurity E |
安乃近雜質(zhì)E |
117-38-4 |
詳細(xì)
|
ValacyclovirEPImpurityP |
伐昔洛韋EP雜質(zhì)P |
1356019-51-6 |
詳細(xì)
|